Clinical Trial Update: Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cannabidiol to prevent chemotherapy-induced peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Zealand University Hospital | Conditions: Chemotherapy-induced Peripheral Neuropathy | Phase 2 | Status: UNKNOWN